Drug-Induced Acute Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
|
25231249 |
2015 |
Chemical and Drug Induced Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
|
25231249 |
2015 |
Chemically-Induced Liver Toxicity
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
|
25231249 |
2015 |
Amyotrophic Lateral Sclerosis, Familial
|
0.300 |
Biomarker
|
disease |
CTD_human |
Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis.
|
11796754 |
2002 |
Liver carcinoma
|
0.240 |
Biomarker
|
disease |
RGD |
Enhanced expression of adaptor molecule p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC rats.
|
15375560 |
2004 |
Liver carcinoma
|
0.240 |
Biomarker
|
disease |
BEFREE |
Shc3 interacted with major vault protein, resulting in activation of MEK1/2 and ERK1/2 independently of Shc1 and c-Raf; this interaction consequently induced epithelial-mesenchymal transition and promoted HCC cell proliferation and metastasis.
|
29330146 |
2018 |
Hepatitis, Chronic
|
0.200 |
Biomarker
|
disease |
RGD |
Enhanced expression of adaptor molecule p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC rats.
|
15375560 |
2004 |
Hyperlipidemia
|
0.200 |
Biomarker
|
disease |
RGD |
Cholesterol diet-induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microarray study.
|
15044008 |
2004 |
Hyperlipoproteinemias
|
0.200 |
Biomarker
|
disease |
RGD |
Cholesterol diet-induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microarray study.
|
15044008 |
2004 |
Liver neoplasms
|
0.200 |
Biomarker
|
group |
RGD |
Enhanced expression of adaptor molecule p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC rats.
|
15375560 |
2004 |
Hepatoblastoma
|
0.200 |
Biomarker
|
disease |
RGD |
Enhanced expression of adaptor molecule p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC rats.
|
15375560 |
2004 |
Malignant neoplasm of liver
|
0.200 |
Biomarker
|
disease |
RGD |
Enhanced expression of adaptor molecule p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC rats.
|
15375560 |
2004 |
hypertensive nephropathy
|
0.200 |
Biomarker
|
disease |
RGD |
p66Shc regulates renal vascular tone in hypertension-induced nephropathy.
|
27270176 |
2016 |
Hepatoblastoma Caused By Somatic Mutation
|
0.200 |
Biomarker
|
disease |
RGD |
Enhanced expression of adaptor molecule p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC rats.
|
15375560 |
2004 |
Malignant neoplasm of breast
|
0.060 |
Biomarker
|
disease |
BEFREE |
Compared with WT tumors, 893 differentially expressed (DE; FDR < 0.05) genes were detected in p52SHC KO tumors compared with only 18 DE genes in the p66SHC KO tumors, further highlighting that p52SHC is the relevant SHC1 isoform in breast cancer.
|
31202267 |
2019 |
Malignant neoplasm of breast
|
0.060 |
Biomarker
|
disease |
BEFREE |
We previously identified the Shc1 (ShcA) scaffold, a central regulator of tyrosine kinase signalling, as essential for promoting breast cancer immune suppression.
|
28276425 |
2017 |
Malignant neoplasm of breast
|
0.060 |
Biomarker
|
disease |
BEFREE |
Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II.
|
18611262 |
2008 |
Malignant neoplasm of breast
|
0.060 |
Biomarker
|
disease |
BEFREE |
We here report that the 66-kDa isoform of the SHC gene (p66Shc) is induced in a breast cancer cell line by the exposure to hypoxic environment and that it controls the expression of the stem cell regulatory gene Notch-3.
|
17158237 |
2007 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
We here report that the 66-kDa isoform of the SHC gene (p66Shc) is induced in a breast cancer cell line by the exposure to hypoxic environment and that it controls the expression of the stem cell regulatory gene Notch-3.
|
17158237 |
2007 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
We previously identified the Shc1 (ShcA) scaffold, a central regulator of tyrosine kinase signalling, as essential for promoting breast cancer immune suppression.
|
28276425 |
2017 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
Compared with WT tumors, 893 differentially expressed (DE; FDR < 0.05) genes were detected in p52SHC KO tumors compared with only 18 DE genes in the p66SHC KO tumors, further highlighting that p52SHC is the relevant SHC1 isoform in breast cancer.
|
31202267 |
2019 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II.
|
18611262 |
2008 |
Prostatic Neoplasms
|
0.030 |
Biomarker
|
group |
LHGDN |
Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells.
|
18504439 |
2008 |
Pancreatic carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.
|
27605668 |
2016 |
Pancreatic carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX.
|
24216611 |
2014 |